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ABSTRACT
The present research was performed to evaluate antioxidant 
activities and enzyme inhibitory potentials of two extracts 
(acetone and methanol) from two parts (flowers and leaves) 
of Mandragora autumnalis. The antioxidant properties were 
evaluated by using different methods. Enzyme inhibitory 
potentials were tested against cholinesterase (AChE and 
BChE), tyrosinase, α-amylase and α-glucosidase.  Fatty acids, 
total phenolics and flavonoid content were investigated for 
phytochemical composition. Generally, the methanolic extract 
of flowers (F-Met) exhibited the strongest antioxidant effect 
with the highest level of phenolics. Total phenolic and flavonoid 
content were determined as 26.10-46.92 mgGAE/g extract and 
3.60-26.11 mgRE/g extract, respectively. α- linolenic acid was 
found to be major fatty acids in the studied oils (33.81 % for 
flowers and 39.15 % for leaves).  The study suggested that M. 
autumnalis could be valuable as a source of natural agents in 
food and pharmaceutical applications. 
Keywords: antioxidant activity, enzyme inhibitory activity, 
Mandragora autumnalis, phenolic compounds.
INTRODUCTION
Plants have great attention as not only food but also sources 
of drugs since long ancient times. In recent decades, plant 
or plant products are thinking as major sources of preparing 
new drugs or functional preparations due to the fact that 
synthetic compounds possess unfavorable side effects against 
human health.  Thus, new researches on plants or theirs 
biological activities are very popular subject in scientific 
area (1). At this point, uninvestigated wild plants could be 
considered as a valuable pool for designing new functional 
products.
 Mandragora L. (Solaneceae) commonly known as Mandrake. 
Mandragora genus is represented by 2 species in Turkey 
namely, M. autumnalis and M. officinarum (2). Mandragora 
autumnalis known by several local names such as at elması, 
yer yenidünyası ( Silifke, Mersin) and köpek elması, insan 
otu, kan kurutan (Kalkan, Kınık, Antalya) in Turkey (3). 
Mandrake dates back thousands of years and it was used 
for surgical anesthesia for 15 centuries (4, 5). In addition, 
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different parts (root, fruit, and leaves) of Mandragora species 
were used as treatment for many diseases [including pain, 
insomnia, eye diseases, inflammation and ulcers] in ancient 
time (6). Several studies were shown the phytochemical 
profile (alkaloids, essential oils, etc.) of Mandragora species 
including M. autumnalis (7, 8, 9, 10). 
In the last few decades, the number of people with diabetes 
and Alzheimer’s has been greatly increased. For instance, 
International Diabetes Federation (IDF) estimated that 
diabetes affected about 415 million people worldwide in 2015 
and it will increased to 642 million by 2040 (11, 12). In this 
context, the exploration of new treatment strategies for these 
global health problems is one of the most important subjects in 
medicinal and pharmaceutical areas. Among these strategies, 
key enzyme inhibition theory is accepted as the most 
valuable approach. From this point, many synthetic enzyme 
inhibitors are produced but they have several side effects 
such as gastrointestinal disturbances and hepatotoxicity (13, 
14). Therefore, leads international efforts have targeted to 
find enzyme inhibitors [cholinesterase enzyme inhibitors for 
Alzheimer’s disease, tyrosinase inhibitors for skin diseases, 
α-amylase and α-glucosidase enzyme inhibitors for diabetes] 
from natural resources. 
With these bases, the objectives of this study were to 
(i) determine the antioxidant properties of two extracts 
(acetone and methanol) of two parts (flowers and leaves) of 
M. autumnalis, (ii) evaluate enzyme inhibitory potentials of 
these extracts against cholinesterase, tyrosinase, amylase and 
glucosidase, and (iii) identify fatty acid compositions of these 
parts. 
MATERIALS AND METHODS
Plant Materials
The flowers and leaves of Mandragora autumnalis were 
collected from Mersin-Silifke, Turkey and was identified 
by Dr. Murad Aydın SANDA.  The voucher specimen was 
deposited in the herbarium of Department of Biology, Selcuk 
University (KNYA); herbarium code number: GZ 1451.
Preparation of the extracts
Aerial plant materials were dried at the room temperature. 
The dried plant materials were ground to a fine powder 
using a laboratory mill. Powdered M. autumnalis flowers and 
leaves [15 g] were extracted with 250 mL of solvent acetone, 
methanol using the by Soxhlet apparatus for 6-8 h. Extracts 
(flowers acetone (F-Ac), flowers methanol (F-Met), leaves 
acetone (L-Ac) and leaves methanol (L-Met)) were then 
filtered and concentrated under vacuum at 40 °C by using a 
rotary evaporator. Extracts were kept at + 4°C in dark until 
analysis. 
Total phenolic content
The total phenolic content was determined by employing the 
methods given in the literature (15) with slight modification. 
Sample solution (0.25 mL) was mixed with diluted Folin-
Ciocalteu reagent (1 mL, 1:9) and shaken vigorously.  After 
3 min, Na2CO3 solution (0.75 mL, 1%) was added and the 
sample absorbance was read at 760 nm after a 2 h incubation 
at room temperature. The total phenolic content was 
expressed as equivalents of gallic acid.
Total flavonoid content 
The total flavonoid content was determined using the Dowd 
method (16). Briefly, sample solution (1 mL) was mixed with 
the same volume of aluminium trichloride (2%) in methanol. 
Similarly, a blank was prepared by adding sample solution 
(1 mL) to methanol (1 mL) without AlCl3. The sample 
and blank absorbances were read at 415 nm after a 10 min 
incubation at room temperature. The absorbance of the blank 
was subtracted from that of the sample. The total flavonoid 
content was expressed as equivalents of rutin 
Free radical scavenging activity (DPPH assay)
The effect of the samples on 1,1-diphenyl-2-picrylhydrazyl 
(DPPH) radical was estimated according to Sarikurkcu (17). 
Sample solution (1 mL) was added to a 4 ml of a 0.004% 
methanol solution of DPPH. The sample absorbance was read 
at 517 nm after a 30 min incubation at room temperature in 
dark. The free radical scavenging activity was expressed as 
equivalents of trolox. 
Phosphomolybdenum method
The total antioxidant activity of the samples was evaluated 
by phosphomolybdenum method according to Berk et al. 
(18) with slight modification. Sample solution (0.3 mL) was 
combined with 3 mL of reagent solution (0.6 M sulfuric 
acid, 28 mM sodium phosphate and 4 mM ammonium 
molybdate). The sample absorbance was read at 695 nm after 
a 90 min incubation at 95 °C. The total antioxidant capacity 
was expressed as equivalents of trolox.
Cupric ion reducing (CUPRAC) method
The cupric ion reducing activity (CUPRAC) was determined 
according to the method of Apak et al (19). Sample solution 
(0.5 mL) was added to premixed reaction mixture containing 
CuCl2 (1 mL, 10 mM), neocuproine (1 mL, 7.5 mM) and 
NH4Ac buffer (1 mL, 1 M, pH 7.0). Similarly, a blank was 
prepared by adding sample solution (0.5 mL) to premixed 
reaction mixture (3 mL) without CuCl2.  Then, the sample 
and blank absorbances were read at 450 nm after a 30 min 
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incubation at room temperature. The absorbance of the blank 
was subtracted from that of the sample. CUPRAC activity 
was expressed as equivalents of trolox.
Ferric reducing antioxidant power (FRAP) method
The FRAP assay was carried out as described by Aktumsek 
et al. (20) with slight modification. Sample solution (0.1 mL) 
was added to premixed FRAP reagent (2 mL) containing 
acetate buffer (0.3 M, pH 3.6), 2,4,6-tris(2-pyridyl)-s-triazine 
(TPTZ) (10 mM) in 40 mM HCl and ferric chloride (20 mM) 
in a ratio of 10:1:1 (v/v/v). Then, the sample absorbance was 
read at 593 nm after a 30 min incubation at room temperature. 
FRAP activity was expressed as equivalents of trolox.
Metal chelating activity on ferrous ions
The metal chelating activity on ferrous ions was determined 
by the method described by Zengin and Aktumsek (21). 
Briefly, sample solution (2 mL) was added to FeCl2 solution 
(0.05 mL, 2 mM). The reaction was initiated by the addition 
of 5 mM ferrozine (0.2 mL). Similarly, a  blank  was  prepared 
by  adding  sample solution (2 mL) to  FeCl2 solution (0.05 
mL, 2 mM) and water (0.2 mL) without ferrozine. Then, the 
sample and blank absorbances were read at 562 nm after 10 
min incubation at room temperature. The absorbance of the 
blank was subtracted from that of the sample. The metal 
chelating activity was expressed as equivalents of EDTA.
Enzyme inhibitory activity 
Cholinesterase inhibition
Cholinesterase (ChE) inhibitory activity was measured using 
Ellman’s method, as previously reported (22) with slight 
modification. Sample solution (50 µL) was mixed with DTNB 
(125 µL) and AChE (or BChE) solution (25 µL) in Tris-HCl 
buffer (pH 8.0) in a 96-well microplate and incubated for 15 
min at 25 °C. The reaction was then initiated with the addition 
of acetylthiocholine iodide (ATCI) or butyrylthiocholine 
chloride (BTCl) (25 µL). Similarly, a blank was prepared 
by adding sample solution to all reaction reagents without 
enzyme (AChE or BChE) solution. The sample and blank 
absorbances were read at 405 nm after a 10 min incubation at 
25 °C. The absorbance of the blank was subtracted from that 
of the sample and the cholinesterase inhibitory activity was 
expressed as equivalents of galanthamine. 
Tyrosinase inhibition
Tyrosinase inhibitory activity was measured using the 
modified dopachrome method with L-DOPA as substrate, 
as previously reported (23) with slight modification. Sample 
solution (25 µL) was mixed with tyrosinase solution (40 
µL) and phosphate buffer (100 µL, pH 6.8) in a 96-well 
microplate and incubated for 15 min at 25 °C. The reaction 
was then initiated with the addition of L-DOPA (40 µL). 
Similarly, a blank was prepared by adding sample solution to 
all reaction reagents without enzyme (tyrosinase) solution. 
The sample and blank absorbances were read at 492 nm after 
a 10 min incubation at 25 °C. The absorbance of the blank 
was subtracted from that of the sample and the tyrosinase 
inhibitory activity was expressed as equivalents of kojic acid. 
α-amylase inhibition
α-amylase inhibitory activity was performed using Caraway-
Somogyi iodine/potassium iodide (IKI) method (24) with 
some modifications. Sample solution (25 µL) was mixed 
with α-amylase solution (50 µL) in phosphate buffer (pH 
6.9 with 6 mM sodium chloride) in a 96-well microplate 
and incubated for 10 min at 37 °C. After pre-incubation, the 
reaction was initiated with the addition of starch solution 
(50 µL, 0.05%). Similarly, a blank was prepared by adding 
sample solution to all reaction reagents without enzyme 
(α-amylase) solution. The reaction mixture was incubated 
10 min at 37 °C. The reaction was then stopped with the 
addition of HCl (25 µL, 1 M). This was followed by addition 
of the iodine-potassium iodide solution (100 µL). The sample 
and blank absorbances were read at 630 nm. The absorbance 
of the blank was subtracted from that of the sample and the 
α-amylase inhibitory activity was expressed as equivalents of 
acarbose. 
α-glucosidase inhibition 
α-glucosidase inhibitory activity was performed by the 
previous method (25) with some modifications. Sample 
solution (50 µL) was mixed with glutathione (50 µL), 
α-glucosidase solution (50 µL) in phosphate buffer (pH 6.8) 
and PNPG (50 µL)  in a  96-well microplate and incubated for 
15 min at 37 °C. Similarly, a blank was prepared by adding 
sample solution to all reaction reagents without enzyme 
(α-glucosidase) solution. The reaction was then stopped with 
the addition of sodium carbonate (50 µL, 0.2 M). The sample 
and blank absorbances were read at 400 nm. The absorbance 
of the blank was subtracted from that of the sample and the 
α-glucosidase inhibitory activity was expressed as equivalents 
of acarbose.
Fatty acid analysis
The oil extraction of dried and powdered plant parts (10 
g) was carried out at boiling point for 6 h using a Soxhlet 
extractor and petroleum ether as a solvent. The solvent was 
evaporated by rotary evaporator. The oil was esterified to 
determine fatty acid composition.  The fatty acids in the oil 
were esterified into methyl esters by saponification with 0.5 
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mol/L methanolic NaOH and transesterified with 14% BF3 
(v/v) in methanol (26).
Fatty acid methyl esters (FAMEs) were analyzed on a HP 
(Hewlett Packard) Agilent 6890N model gas chromatograph 
(GC), equipped with a flame ionization detector (FID) and 
fitted to a HP-88 capillary column (100 m, 0.25 mm i.d. and 
0.2 µm). Injector and detector temperatures were set at 250 
and 280 ºC, respectively. The oven was programmed at 60 
ºC initial temperature and 1 min initial time. Thereafter 
the temperature was increased up to 190 °C rate of 20 °C/
min-1 held for 60 min then increased at 1 °C/min to 220 °C 
and held for 10 min at 220°. Total run time was 107.5 min. 
Helium was used as carrier gas (1 mL/min). Identification of 
fatty acids was carried out by comparing sample FAME peak 
relative retention times with those obtained for Alltech and 
Accu standards. Results were expressed as FID response area 
in relative percentages. Each reported result is given as the 
average value of three GC analyses.
Statistical analysis
For all the experiments all the assays were carried out in 
triplicate. The results are expressed as mean values and 
standard deviation (SD). The differences between the 
different extracts were analyzed using one-way analysis of 
variance (ANOVA) followed by Tukey’s honestly significant 
difference post hoc test with α = 0.05. This treatment was 
carried out using SPSS v. 14.0 program.
Results and Discussion
Total phenolic and flavonoid contents of M. autumnalis 
extracts and fatty acid profile
Secondary metabolites including alkaloids, flavonoids, 
tannins and saponins are usually generated by plants that 
serve as defence mechanism (27). Phenolic compounds are 
one of the most commonly occurring groups of seconder 
metabolites. Plant phenolic possess important functions 
including antiallergenic, antimicrobial, antiartherogenic, 
antithrombotic, antiinflammatory, vasodilatory and 
cardioprotective effects (28, 29). Indeed, polyphenols showed 
potent antioxidant activity (30, 31). For this reason, phenolic 
compounds have great interest in recent years. The total 
phenolic contents of M. autumnalis extracts ranged from 
26.10 to 46.92 mgGAE/g extract. F-Met extract contained 
the highest total phenolic contents (46.92 mgGAE/g extract), 
followed by L-Ac (40.09 mgGAE/g extract) and F-Ac 
(32.12 mgGAE/g extract). The amount of phenolic content 
in extracts changed according to the plant part and the 
solvent.  In accordance with our previous study, the phenolic 
content may vary significantly between the different plant 
parts (21, 32). The highest levels of flavonoids were detected 
in the L-Met and F-Ac (26.11 and 13.08 mgRE/g extract, 
respectively) (Table 1).
Table 1. Total phenolic and flavonoid content and total 
antioxidant capacity (by phosphomolybdenum assay) of 
Mandragora autumnalis.
Plants 
parts
Solvent Total phenolic 
content
(mgGAE/g 
extract)a
Total 
flavonoid 
content
(mgRE/g 
extract)b
Phosphomo-
lybdenum
(mmolTE/g 
extract)c
Flowers Acetone 32.12±0.49* 13.08±0.70 1.14±0.01
Methanol 46.92±0.96 4.09±0.10 1.20±0.05
Leaves Acetone 40.09±0.56 3.60±0.25 1.98±0.01
Methanol 26.10±0.36 26.11±0.09 1.03±0.03
a GAEs. gallic acid equivalents
b REs. rutin equivalents
c TEs. trolox equivalents
*Values expressed are means ±SD
Clinical and epidemiologic studies have shown that many 
chronic diseases are related to fatty acid type (33).  Also, some 
fatty acids also exhibited very important biological activities 
such as anti-diabetic, anti-bacterial and anti-inflammatory 
(34). Again, plant oils could considered as healthy oils due 
to high concentrations of polyunsaturated fatty acids. In 
this sense, we investigated the fatty acid compositions of the 
flowers and leaves of M. autumnalis. The results are listed in 
Table 2. The most predominant fatty acids were α-linoleic acid 
(C18:3 ω 3), linoleic acid (C18:2 ω6), palmitic acid (C16:0). 
Polyunsaturated fatty acids (PUFAs) were the major group 
of the fatty acids in flowers and leaves. Similar results were 
reported by our previous study (26, 35). According to Table 2, 
there no important differences in the two parts (flowers and 
leaves) for the fatty acid composition. The results indicated 
that the M. autumnalis can be considered as a source of 
essential fatty acids (α-linoleic acid and linoleic acid). 
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Table 2. Fatty acid composition of M. autumnalis (flowers 
and leaves).
Flowers Leaves
C 8:0 0.03±0.01a 0.02±0.00
C 10:0 0.03±0.01 0.04±0.01
C 12:0 0.06±0.01 1.33±0.64
C 13:0 0.03±0.01 2.98±0.06
C 14:0 0.74±0.01 1.04±0.03
C 15:0 0.38±0.01 0.15±0.00
C 16:0 27.69±0.07 21.76±0.05
C 17:0 0.26±0.01 0.19±0.01
C 18:0 4.59±0.03 4.95±0.14
C 20:0 0.01±0.01 0.02±0.00
C 21:0 0.06±0.01 0.15±0.02
C 22:0 0.01±0.01 0.02±0.01
ΣSFAb 33.88±0.11 32.62±0.53
C 14:1 ω5 0.03±0.01 0.43±0.04
C 15:1 ω5 0.15±0.01 0.48±0.09
C 16:1 ω7 0.17±0.01 0.22±0.00
C 17:1 ω7 0.01±0.01 0.21±0.04
C 18:1 n9 1.82±0.01 0.52±0.01
C 20:1 ω9 0.09±0.01 0.20±0.03
ΣMUFAb 2.25±0.02 2.05±0.03
C 18:2 ω6 27.10±0.04 23.14±0.10
C 18:3n6 1.95±0.12 1.53±0.25
C 18:3n3 33.81±0.03 39.15±0.17
C 20:2 ω6 1.00±0.04 1.48±0.02
ΣPUFAb 63.85±0.23 65.30±0.54
ΣUFAb 66.10±0.25 67.35±0.57
EFAb 60.91±0.06 62.29±0.27
aValues reported are means ±S.D.  b SFA: Saturated fatty acids, 
MUFA: Monounsaturated fatty acids, PUFA: Polyunsaturated fatty 
acids,  UFA:Unsaturated fatty acids, EFA: Essential fatty acids
Antioxidant activity
Total antioxidant capacity was evaluated by 
phosphomolybdenum method. The method is based on 
the reduction of Mo (VI) to Mo (V) by antioxidants and 
subsequent formation of green phosphate/Mo (V) complex 
at acidic pH (about 2). In phosphomolybdenum assay, total 
antioxidant capacity did not vary greatly between extracts, 
and the values ranged from 1.03 to 1.98 mmolTE/g extract. 
Total antioxidant capacity of the extracts was higher in L-Ac 
[1.98 mmolTE/g extract] followed by F-Met [1.20 mmolTE/g 
extract] > F-Ac [1.14 mmolTE/g extract] and L-Met [1.03 
mmolTE/g extract]. Total antioxidant capacity of the extracts 
may be due to bioactive compounds [such as phenolic 
and flavonoids]. Our result confirmed previous finding of 
Nagulsamy et al., (36).
Free radical scavenging activity of extracts were evaluated 
by DPPH assay. The DPPH method has been widely used 
to determine antioxidant activity because of it is an easy, 
rapid, and stable (37). F-Met has the strongest free radical 
scavenging activity with 73.09 mg TE/g extract compared 
to the other extracts, while L-Ac the weakest activity. F-Met 
containing the highest amount of phenolic content exhibited 
the strongest DPPH radical scavenging activity. The phenolic 
content may be attributed to DPPH radical scavenging 
activity of F-Met. As for Metal chelating activity, the highest 
chelating activity was found in F-Met [15.94 mgEDTA/g 
extract], followed by F-Ac [15.61 mgEDTA/g extract] > 
L-Met [11.64 mgEDTA/g extract] > L-Ac [6.15 mgEDTA/g 
extract]. The metal chelating activities of the extracts varied 
according to the plant parts as well as the solvent used.
Reducing abilities of plants may serve as an important 
indicator of its antioxidant activity. Reducing abilities were 
assessed by FRAP and CUPRAC assays. FRAP and CUPRAC 
assays have been widely used to determine the antioxidant 
activity of plants.   The FRAP values of extracts varied 
significantly (50.41 to 90.88 mg TE/g extract). The FRAP 
values of extracts decreased in the order of F- Met [90.88 
mgTE/g extract] > L-Ac [53.53 mgTE/g extract] > L-Met 
[53.29 mgTE/g extract] > F-Ac [50.41 mgTE/g extract]. 
Similar results for CUPRAC are reported in present study 
(Table 3). F-Met [113.24 mgTE/g extract] had the highest 
CUPRAC value, followed by L-Ac [86.55 mgTE/g extract] 
> L-Met [77.98 mgTE/g extract] > F-Ac [77.47 mgTE/g 
extract]. Our results showed that reducing power activity 
of F-Met may dependent on total phenolic content. These 
results are accordance with the report earlier published in 
literature (38).
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Enzyme inhibitory activity
Plants and their products open a new era for prevention 
or treatment common disease in worldwide. Thus, enzyme 
inhibitory activities of M. autumnalis were assessed against 
the enzymes linked to diabetes, Alzheimer’s and skin diseases. 
The cholinesterase inhibitory activities of M. autumnalis 
were tested against AChE and BChE enzymes, which are 
connected to Alzheimer’s disease. The F-Met extract was 
the most potent activity for AChE, while L-Ac exhibited 
remarkable inhibitory activity on BChE. The flowers and 
leaves of M. autumnalis were evaluated to determine their 
effect on α-amylase and α-glucosidase. α-amylase inhibitory 
activity of extracts decreased in the order of L-Ac [1.86 
mmolACAE/g extract] > F-Ac [1.27 mmolACAE/g extract] 
> L-Met [0.51 mmolACAE/g extract] > F-Met [0.46 
mmolACAE/g extract]. For α-amylase, acetone extract 
had stronger activity than methanol extract. In constrat to 
α-amylase assay, L-Ac extract showed no inhibitory activity 
of α-glucosidase. Inhibitory activities of all extracts against 
α-amylase were found to be more potent than α-glucosidase. 
The tyrosinase inhibitory activities of the M. autumnalis are 
shown in Fig 1. The highest tyrosinase inhibitory activity was 
L-Ac [29.68 mgKAE/g extract]. F-Met exhibited no inhibitory 
activity aganist tyrosinase. The inhibition of tyrosinase 
activity can be dependent on the hydroxyl group of phenolic 
compounds in M. autumnalis. These findings are accordance 
with Prasad et al., (39), Fatiha et al., (40) and Zengin et al., 
(32). In the literature, no publications were found about the 
antioxidant and enzyme inhibitory activity of M. autumnalis 
Table 3. Free radical (DPPH) scavenging activity, reducing power (FRAP and CUPRAC) and metal chelating activity of 
Mandragora autumnalis.
Plants parts Solvent DPPH (mgTE/g extract)a
FRAP 
(mgTE/g extract)a
CUPRAC
 (mgTE/g extract)a
Metal chelating activity
(mgEDTA/g extract)b
Flowers Acetone 39.30±0.10* 50.41±0.16 77.47±0.48 15.61±0.08
Methanol 73.09 ±0.08 90.88±2.06 113.24±1.89 15.94±0.78
Leaves Acetone 33.19±0.13 53.53±0.86 86.55±0.90 6.15±0.24
Methanol 51.44±0.29 53.29±0.26 77.98±0.76 11.64±1.10
aTEs. trolox equivalents
bEDTAEs. disodium edetate equivalents
*Values expressed are means ±SD
Figure 1. a. Acetylcholinesterase and Butyrylcholinesterase 
inhibitory activity (GALAEs, galanthamine equivalets).
Figure 1. b. α-amylase and α-glucosidase inhibitory activity 
(ACEs, acarbose equivalents).
Figure 1. c. Tyrosinase inhibitory activity (KAEs, kojic acid 
equivalents).
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Conclusion
The present study carried out in order to evaluate to 
antioxidant and enzyme inhibitory activity of flowers and 
leaves extracts of M. autumnalis. In the present study, the 
values of antioxidant and enzyme inhibitory activity vary 
among the different solvent and plant parts. Generally, 
F-Met showed the strongest antioxidant activity with the 
higher concentration of phenolics.  M. autumnalis extract 
indicated remarkable inhibitory effects on cholinesterase, 
tyrosinase, amylase and glucosidase. Moreover, the oils 
obtained from flowers and leaves of M. autumnalis contained 
the higher concentrations of polyunsaturated fatty acids. 
Taken together, the results suggested that M. autumnalis 
could be considered as a source of natural agents in food and 
pharmaceutical applications.
Mandragora autumnalis özütlerinin enzim inhibitor 
etkileri ve antioksidan özellikleri ile yağ asidi 
komposizyonu
ÖZ
Mevcut araştırma, Mandragora autumnalis’in iki farklı 
kısmından (çiçek ve yaprak) elde edilen iki özütün (aseton 
ve metanol) antioksidan aktivitesini ve enzim inhibitör 
potansiyelini değerlendirmek için gerçekleştirdi. Antioksidan 
özellikler farklı metotlar kullanılarak değerlendirildi. Enzim 
inhibitör potansiyelleri kolinesteraz [AChE ve BChE], tirozinaz, 
α-amilaz ve α-glukozidaz enzimlerine karşı test edildi. Yağ 
asitleri, total fenolik ve flavonoid içerik fitokimyasal bileşim 
için araştırıldı. Genellikle, çiçek metanol özütü (F-Met) yüksek 
seviyede fenolik ile güçlü antioksidan etki sergiledi. Total 
fenolik ve flavonoid içerik sırasıyla 26.10-46.92 mgGAE/g özüt 
ve 3.60-26.11 mgRE/g özüt olarak belirlenmiştir. α- linolenik 
asit çalışılan yağlarda [çiçek için %33.81 ve yaprak için %39.15) 
major yağ asidi olarak bulundu. Bu çalışma Mandragora 
autumnalis bitkisinin gıda ve ilaç uygulamalarında doğal ajan 
olarak değerli olabileceğini önermektedir. 
Anahtar kelimeler: Antioksidan aktivite, enzim inhibitör 
aktivite, Mandragora autumnalis, fenolik bileşikler.
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